Catalyst Wire Dossier Catalyst Wire Dossier

RD13-02 CAR-T cell therapy

RD13-02 CAR-T
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RD13-02 CAR-T cell therapy, covering 2024-11-21 to 2024-11-21. Get the full timeline:

Most recent: Clinical Trial Update: RD13-02 CAR-T Cell Injection for Patients With r/r CD7+ T-ALL/T-LBL [EARLY_Phase 1]

See pricing